Trevi Therapeutics
TRVI
TRVI
20 hedge funds and large institutions have $63.5M invested in Trevi Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
40% less capital invested
Capital invested by funds: $106M → $63.5M (-$42.8M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$146K | |
| 2 | +$111K | |
| 3 | +$52K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.36K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$4K |
Top Sellers
| 1 | -$295K | |
| 2 | -$178K | |
| 3 | -$92K | |
| 4 |
Morgan Stanley
New York
|
-$48.6K |
| 5 |
BlackRock
New York
|
-$9.97K |